Janumet is a prescription medicine used in the treatment of type 2 diabetes mellitus in adults. It contains two active substances, sitagliptin and metformin, which work together to help control blood glucose levels. Janumet is prescribed as part of a comprehensive treatment plan that includes diet, physical activity, and regular medical monitoring.<\/p>\n
Metformin works primarily by reducing glucose production in the liver and improving the body\u2019s sensitivity to insulin. Sitagliptin belongs to a group of medicines known as DPP-4 inhibitors and works by increasing the levels of hormones that stimulate insulin release after meals and reduce glucose production. By combining these two mechanisms, Janumet helps improve overall glycaemic control.<\/p>\n
Janumet is intended for patients with type 2 diabetes whose blood sugar levels are not adequately controlled with lifestyle measures alone or with one of the components separately. It is not suitable for the treatment of type 1 diabetes or diabetic ketoacidosis.<\/p>\n
Janumet is taken orally and is intended for long-term use under medical supervision. Regular monitoring of blood glucose levels and kidney function is important during treatment. As with all prescription medicines, Janumet should only be used after a medical assessment and according to the instructions provided by a licensed physician.<\/p>\n","protected":false},"excerpt":{"rendered":"